BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6433960)

  • 1. A comparison of the plasma profiles of two slow release theophylline preparations in asthmatic patients and healthy volunteers.
    Langaker KE; Bredesen JE; Holland A
    Br J Clin Pract Suppl; 1984; 35():50-2. PubMed ID: 6433960
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels and spirometric response with sustained release theophylline].
    Otero MJ; Barrueco M; Mariño EL; Gómez F; de Portugal J; Domínguez-Gil A
    Med Clin (Barc); 1985 Jan; 84(2):51-3. PubMed ID: 3974347
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multicenter study of a slow-release theophylline: armophylline].
    Akoun G; Battesti JP; Bignon J; Caubarrere I; Charpin J; Chicou JF; Godard P; Herman DM; Julien D; Michel FB
    Poumon Coeur; 1983; 39(6):333-6. PubMed ID: 6364093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma theophylline concentrations in asthmatic children receiving a twice daily theophylline preparation.
    Teo J; Lee HS; Teo PC
    Singapore Med J; 1986 Jun; 27(3):210-3. PubMed ID: 3764456
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.
    Talseth T; Boye NP; Bredesen JE; Kornstad S
    Ann Allergy; 1981 May; 46(5):279-80. PubMed ID: 7235323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of plasma theophylline levels in asthmatic patients treated with oxtriphylline].
    Morell F; Orriols R; Roca I; Fraile M; Laporte JR
    Arch Farmacol Toxicol; 1983 Apr; 9(1):89-94. PubMed ID: 6625679
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-effect relationship of a controlled release theophylline preparation in pre-school children.
    Duiverman EJ; Neijens HJ; Kerrebijn KF
    Br J Clin Pract Suppl; 1984; 35():55-6. PubMed ID: 6433962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of circadian variation in serum theophylline levels in the sustained-release theophylline treatment of chronic asthma].
    Watanabe A; Urata C; Nomoto H; Mizobe M; Abe Y; Mano K; Miyamato Y; Sano Y
    Arerugi; 1986 Jul; 35(7):447-54. PubMed ID: 3778214
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of sustained release Somophyllin-12 capsules in young asthmatic children.
    Newth CJ; Isles AF
    Br J Clin Pract Suppl; 1984; 35():64-7. PubMed ID: 6433964
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
    Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H; Bauer J; Schwandt HJ
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute and relative bioavailability of a slow release theophylline preparation in asthmatic children.
    Boner AL; De Stefano G; Vallone G; Plebani M; Ventura P
    J Int Med Res; 1987; 15(5):282-92. PubMed ID: 3678595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release theophylline therapy in Thai asthmatic children.
    Tuchinda M; Habanananda S; Srimaruta N; Chaichanwathanakul K; Geadsomnuig S
    J Med Assoc Thai; 1985 Feb; 68(2):81-6. PubMed ID: 4009090
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retard theophylline in the treatment of asthma].
    Suskovic S; Jurcic B; Varga T; Furlan J
    Plucne Bolesti; 1986; 38(3-4):270-2. PubMed ID: 3588750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.